Bank Julius Baer & Co’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $125M | Buy |
233,263
+16,297
| +8% | +$8.74M | 0.37% | 74 |
|
2025
Q1 | $99M | Sell |
216,966
-6,875
| -3% | -$3.14M | 0.32% | 80 |
|
2024
Q4 | $99.1M | Buy |
223,841
+15,565
| +7% | +$6.89M | 0.31% | 78 |
|
2024
Q3 | $119M | Buy |
208,276
+4,348
| +2% | +$2.49M | 0.4% | 63 |
|
2024
Q2 | $108M | Sell |
203,928
-14,908
| -7% | -$7.9M | 0.41% | 58 |
|
2024
Q1 | $118M | Buy |
218,836
+7,135
| +3% | +$3.85M | 0.45% | 61 |
|
2023
Q4 | $118M | Buy |
211,701
+43,844
| +26% | +$24.3M | 0.5% | 58 |
|
2023
Q3 | $73.4M | Buy |
167,857
+11,575
| +7% | +$5.06M | 0.43% | 60 |
|
2023
Q2 | $78.5M | Sell |
156,282
-2,787
| -2% | -$1.4M | 0.47% | 55 |
|
2023
Q1 | $79.5M | Sell |
159,069
-2,712
| -2% | -$1.36M | 0.51% | 54 |
|
2022
Q4 | $66M | Buy |
161,781
+451
| +0.3% | +$184K | 0.45% | 59 |
|
2022
Q3 | $52.6M | Sell |
161,330
-2,932
| -2% | -$955K | 0.4% | 63 |
|
2022
Q2 | $57.6M | Buy |
164,262
+4,242
| +3% | +$1.49M | 0.41% | 61 |
|
2022
Q1 | $87.5M | Buy |
160,020
+3,021
| +2% | +$1.65M | 0.52% | 49 |
|
2021
Q4 | $103M | Buy |
156,999
+20,315
| +15% | +$13.4M | 0.55% | 45 |
|
2021
Q3 | $85M | Buy |
136,684
+13,710
| +11% | +$8.53M | 0.53% | 48 |
|
2021
Q2 | $77.7M | Buy |
122,974
+5,099
| +4% | +$3.22M | 0.49% | 49 |
|
2021
Q1 | $57.7M | Sell |
117,875
-43,541
| -27% | -$21.3M | 0.43% | 55 |
|
2020
Q4 | $80.7M | Buy |
161,416
+154,591
| +2,265% | +$77.3M | 0.66% | 41 |
|
2020
Q3 | $2.68M | Buy |
6,825
+1,225
| +22% | +$482K | 0.03% | 194 |
|
2020
Q2 | $1.85M | Sell |
5,600
-2,396
| -30% | -$791K | 0.02% | 201 |
|
2020
Q1 | $1.94M | Buy |
+7,996
| New | +$1.94M | 0.04% | 156 |
|